Medical Information
Afrique
 

This medical information website is intended only for healthcare professionals in Africa. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

I am a healthcare professional registered to practice in AfricaYes, I am a healthcare professional
SelectI am a healthcare professional registered to practice in AfricaYes, I am a healthcare professional
I am not a Healthcare ProfessionalNo, go back to the patient portal
SelectI am not a Healthcare ProfessionalNo, go back to the patient portal
Where do you work / live?
SubmitSubmit
I am a Healthcare Professional in another country.

Congress Materials

The information on this page pertains to selected congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.

Poster
Silverberg J, Thyssen J, Lazariciu I, Valdez H, Myers D, Guler E, Chovatiya R September 10, 2022 EADV 2022 Atopic Dermatitis

Abrocitinib Improves Itch and Quality of Life in Patients With Itch-Dominant Atopic Dermatitis

View Presentation
Poster
Thyssen J, Bewley A, Ständer S, Castro C, Misery L, Kim B, Biswas P, Chan G, Myers D, Watkins M, Alderfer J, Guler E, Silverberg J September 10, 2022 EADV 2022 Atopic Dermatitis

Abrocitinib Improves Skin Pain and Quality of Life Outcomes in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis

View Presentation
Oral Presentation
Guttman-Yassky E, Weidinger S, Bissonette R, Armstrong A, Seneschal J, Eyerich K, Estrada Y, Pavel A, Xu D, Chen A, Tatulych S, Guler E, Chan G, Page K, Kerkmann U, Valdez H September 10, 2022 EADV 2022 Atopic Dermatitis

Abrocitinib Reduces the Levels of Key Biomarkers Associated With Atopic Dermatitis in the Skin of Patients With Moderate-to-Severe Atopic Dermatitis

View Presentation
Oral Presentation
Bissonnette R, Worm M, Shi V, Zhang F, Chan G, Bratt T, Kerkmann U, Clibborn C September 10, 2022 EADV 2022 Atopic Dermatitis

Efficacy of Abrocitinib and Dupilumab on Chronic Hand Eczema in Patients With Moderate-to-Severe Atopic Dermatitis: Results From the Phase 3 JADE DARE Study

View Presentation
Oral Presentation
Danby S, Matcher S, Byers R, Taylor R, Sahib S, Andrew P, Brown K, Kay L, Wright C, Pinnock A, Chittock J, Cha A, Adiri R, Zang C, Werth J, Cork M September 10, 2022 EADV 2022 Atopic Dermatitis

Novel non-invasive skin biomarkers discriminate topical anti-inflammatory treatments based on their potential for local adverse effects

View Presentation
Poster
Di J, Christakis Y, Mamashli F, Kelekar A, Bruno J, Zhang Y, Northcott C September 10, 2022 EADV 2022 Atopic Dermatitis

One scratch at a time: Nocturnal Scratch and Sleep improvements in Atopic Dermatitis with Abrocitinib

View Presentation
Poster
Feldman S, Thyssen J, Boeri M, Gerber R, Neary M, Cha A, Hauber B, Cappelleri J, Xenakis J, Leach C, Zeichner J September 10, 2022 EADV 2022 Atopic Dermatitis

Preferences for Topical Treatments in Patients With Mild-to-Moderate Atopic Dermatitis

View Presentation
Poster
Simpson E, Silverberg J, Nosbaum A, Winthrop K, Guttman-Yassky E, Hoffmeister K, Egeberg A, Valdez H, Fan H, Farooqui S, Chan G, Alderfer J, Romero W, Johnson S September 10, 2022 EADV 2022 Atopic Dermatitis

Safety of Abrocitinib in 3582 Patients With Moderate-to-Severe Atopic Dermatitis With Over 900 Patients Exposed for Almost 2 Years

View Presentation
Poster
Hang Li, Hao Cheng, Qianjin Lu, Wei Lai, Xiaohua Tao, Gerardo A. Encinas, Shefali Vyas, Bo Wang, Xin Luo, Shiqi Li December 11, 2022 RAD Dec 2022 Atopic Dermatitis

Efficacy and safety of abrocitinib in Chinese patients with moderate-to-severe atopic dermatitis: a post hoc sub-analysis of the JADE REGIMEN phase 3 trial

View Presentation
Oral Presentation
Jonathan I. Silverberg, Sonja Ständer, Jacob P. Thyssen, Brian S. Kim, Carla Castro, Anthony Bewley, Laurent Misery, Andrew G. Bushmakin, Joseph C. Cappelleri, Erman Guler, Justine Alderfer, Melisa Watkins, Gary Chan, Daniela E. Myers December 11, 2022 RAD Dec 2022 Atopic Dermatitis

Examining the Relationships Among Abrocitinib Treatment, Itch, Skin Pain, and Dermatology-specific Quality of Life in Patients With Atopic Dermatitis: A Mediation Modelling Analysis

View Presentation